AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-12-18

AUTHORS

Marc Bosiers, On Behalf of the AMS INSIGHT Investigators

ABSTRACT

Endoluminal treatment of infrapopliteal artery lesions is a matter of controversy. Bioabsorbable stents are discussed as a means to combine mechanical prevention of vessel recoil with the advantages of long-term perspectives. The possibility of not having a permanent metallic implant could permit the occurrence of positive remodeling with lumen enlargement to compensate for the development of new lesions. The present study was designed to investigate the safety of absorbable metal stents (AMSs) in the infrapopliteal arteries based on 1- and 6-month clinical follow-up and efficacy based on 6-month angiographic patency. One hundred seventeen patients with 149 lesions with chronic limb ischemia (CLI) were randomized to implantation of an AMS (60 patients, 74 lesions) or stand-alone percutaneous transluminal angioplasty (PTA; 57 patients, 75 lesions). Seven PTA-group patients “crossed over” to AMS stenting. The study population consisted of patients with symptomatic CLI (Rutherford categories 4 and 5) and de novo stenotic (>50%) or occlusive atherosclerotic disease of the infrapopliteal arteries who presented with a reference diameter of between 3.0 and 3.5 mm and a lesion length of <15 mm. The primary safety endpoint was defined as absence of major amputation and/or death within 30 days after index intervention and the primary efficacy endpoint was the 6-month angiographic patency rate as confirmed by core-lab quantitative vessel analysis. The 30-day complication rate was 5.3% (3/57) and 5.0% (3/60) in patients randomized for PTA alone and PTA followed by AMS implantation, respectively. On an intention-to-treat basis, the 6-month angiographic patency rate for lesions treated with AMS (31.8%) was significantly lower (p = 0.013) than the rate for those treated with PTA (58.0%). Although the present study indicates that the AMS technology can be safely applied, it did not demonstrate efficacy in long-term patency over standard PTA in the infrapopliteal vessels. More... »

PAGES

424-435

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00270-008-9472-8

DOI

http://dx.doi.org/10.1007/s00270-008-9472-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029013758

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19093148


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Absorbable Implants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ischemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lower Extremity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peripheral Vascular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Statistics, Nonparametric", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Patency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Vascular Surgery, AZ St-Blasius, Kroonveldlaan 50, 9200, Dendermonde, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.420039.c", 
          "name": [
            "Department of Vascular Surgery, AZ St-Blasius, Kroonveldlaan 50, 9200, Dendermonde, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bosiers", 
        "givenName": "Marc", 
        "id": "sg:person.01226555721.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226555721.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Vascular Surgery, AZ St-Blasius, Kroonveldlaan 50, 9200, Dendermonde, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.420039.c", 
          "name": [
            "Department of Vascular Surgery, AZ St-Blasius, Kroonveldlaan 50, 9200, Dendermonde, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "On Behalf of the AMS INSIGHT Investigators", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00270-004-0341-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028836413", 
          "https://doi.org/10.1007/s00270-004-0341-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00270-005-0276-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044818355", 
          "https://doi.org/10.1007/s00270-005-0276-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00270-007-9292-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042339227", 
          "https://doi.org/10.1007/s00270-007-9292-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00330-006-0526-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023197907", 
          "https://doi.org/10.1007/s00330-006-0526-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-12-18", 
    "datePublishedReg": "2008-12-18", 
    "description": "Endoluminal treatment of infrapopliteal artery lesions is a matter of controversy. Bioabsorbable stents are discussed as a means to combine mechanical prevention of vessel recoil with the advantages of long-term perspectives. The possibility of not having a permanent metallic implant could permit the occurrence of positive remodeling with lumen enlargement to compensate for the development of new lesions. The present study was designed to investigate the safety of absorbable metal stents (AMSs) in the infrapopliteal arteries based on 1- and 6-month clinical follow-up and efficacy based on 6-month angiographic patency. One hundred seventeen patients with 149 lesions with chronic limb ischemia (CLI) were randomized to implantation of an AMS (60 patients, 74 lesions) or stand-alone percutaneous transluminal angioplasty (PTA; 57 patients, 75 lesions). Seven PTA-group patients \u201ccrossed over\u201d to AMS stenting. The study population consisted of patients with symptomatic CLI (Rutherford categories 4 and 5) and de novo stenotic (>50%) or occlusive atherosclerotic disease of the infrapopliteal arteries who presented with a reference diameter of between 3.0 and 3.5\u00a0mm and a lesion length of\u00a0<15\u00a0mm. The primary safety endpoint was defined as absence of major amputation and/or death within 30\u00a0days after index intervention and the primary efficacy endpoint was the 6-month angiographic patency rate as confirmed by core-lab quantitative vessel analysis. The 30-day complication rate was 5.3% (3/57) and 5.0% (3/60) in patients randomized for PTA alone and PTA followed by AMS implantation, respectively. On an intention-to-treat basis, the 6-month angiographic patency rate for lesions treated with AMS (31.8%) was significantly lower (p\u00a0=\u00a00.013) than the rate for those treated with PTA (58.0%). Although the present study indicates that the AMS technology can be safely applied, it did not demonstrate efficacy in long-term patency over standard PTA in the infrapopliteal vessels.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00270-008-9472-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1091062", 
        "issn": [
          "0174-1551", 
          "1432-086X"
        ], 
        "name": "CardioVascular and Interventional Radiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "keywords": [
      "chronic limb ischemia", 
      "angiographic patency rates", 
      "limb ischemia", 
      "infrapopliteal arteries", 
      "patency rates", 
      "infrapopliteal artery lesions", 
      "PTA group patients", 
      "primary safety endpoint", 
      "primary efficacy endpoint", 
      "percutaneous transluminal angioplasty", 
      "critical limb ischemia", 
      "metal stent implantation", 
      "long-term patency", 
      "major amputation", 
      "standard PTA", 
      "endoluminal treatment", 
      "safety endpoint", 
      "efficacy endpoint", 
      "treat basis", 
      "artery lesions", 
      "transluminal angioplasty", 
      "complication rate", 
      "index intervention", 
      "new lesions", 
      "angiographic patency", 
      "atherosclerotic disease", 
      "infrapopliteal vessels", 
      "positive remodeling", 
      "present study", 
      "stent implantation", 
      "vessel recoil", 
      "absorbable metal stents", 
      "study population", 
      "lumen enlargement", 
      "matter of controversy", 
      "mechanical prevention", 
      "metal stents", 
      "patients", 
      "reference diameter", 
      "lesions", 
      "quantitative vessel analysis", 
      "lesion length", 
      "vessel analysis", 
      "ischemia", 
      "patency", 
      "artery", 
      "implantation", 
      "stents", 
      "endpoint", 
      "efficacy", 
      "treatment", 
      "bioabsorbable stents", 
      "PTA", 
      "permanent metallic implants", 
      "angioplasty", 
      "Stenotic", 
      "amputation", 
      "disease", 
      "prevention", 
      "death", 
      "rate", 
      "remodeling", 
      "intervention", 
      "enlargement", 
      "study", 
      "implants", 
      "days", 
      "vessels", 
      "safety", 
      "metallic implants", 
      "population", 
      "controversy", 
      "absence", 
      "occurrence", 
      "analysis", 
      "development", 
      "intention", 
      "diameter", 
      "length", 
      "long-term perspective", 
      "possibility", 
      "recoil", 
      "means", 
      "basis", 
      "AMS technology", 
      "perspective", 
      "matter", 
      "advantages", 
      "technology"
    ], 
    "name": "AMS INSIGHT\u2014Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis", 
    "pagination": "424-435", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029013758"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00270-008-9472-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19093148"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00270-008-9472-8", 
      "https://app.dimensions.ai/details/publication/pub.1029013758"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_453.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00270-008-9472-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00270-008-9472-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00270-008-9472-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00270-008-9472-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00270-008-9472-8'


 

This table displays all metadata directly associated to this object as RDF triples.

248 TRIPLES      22 PREDICATES      138 URIs      126 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00270-008-9472-8 schema:about N0121037a92c94785803a67770cd8a70e
2 N09001539ad224d438cadd2001dcdb51d
3 N0948feaa1a9240dd928dad22e72e2495
4 N16bc65a5fa62486cab27d0567c00a22c
5 N212c22cb7c0a432da949f7fc53e09cb9
6 N2b935f9034be4ea0bf8b18d682a215f0
7 N3b31540410444102bf815865e680d17e
8 N4b6652cecf92403ca096db07574e162f
9 N55534280ca6942d0949211db86bcd622
10 N619cb0b27a98419696362bb649e2fd68
11 N7118d9a19a6248b48a33b65a8758f2e8
12 N83f4e6fc79424d9098c48e4b506bf48d
13 N8b46f606afd4459f9eeaf14b0ae61a1b
14 Na699c2f48a8c4fcabcfebc69a0803868
15 Na95dc6e65b0a4dcbacea79686654889b
16 Nac3b44e76db14a4989e177c5ae8f1299
17 Nb2b8ffc2ba11458983981e3db18e23f5
18 Ndf4e6d7a3dea4a74b19ffcebf921b45b
19 Nf6fb31a0f58b4790899f7e42f831d06a
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author Nc2eb35057e1f41fdb322db8783b54e06
23 schema:citation sg:pub.10.1007/s00270-004-0341-9
24 sg:pub.10.1007/s00270-005-0276-9
25 sg:pub.10.1007/s00270-007-9292-2
26 sg:pub.10.1007/s00330-006-0526-5
27 schema:datePublished 2008-12-18
28 schema:datePublishedReg 2008-12-18
29 schema:description Endoluminal treatment of infrapopliteal artery lesions is a matter of controversy. Bioabsorbable stents are discussed as a means to combine mechanical prevention of vessel recoil with the advantages of long-term perspectives. The possibility of not having a permanent metallic implant could permit the occurrence of positive remodeling with lumen enlargement to compensate for the development of new lesions. The present study was designed to investigate the safety of absorbable metal stents (AMSs) in the infrapopliteal arteries based on 1- and 6-month clinical follow-up and efficacy based on 6-month angiographic patency. One hundred seventeen patients with 149 lesions with chronic limb ischemia (CLI) were randomized to implantation of an AMS (60 patients, 74 lesions) or stand-alone percutaneous transluminal angioplasty (PTA; 57 patients, 75 lesions). Seven PTA-group patients “crossed over” to AMS stenting. The study population consisted of patients with symptomatic CLI (Rutherford categories 4 and 5) and de novo stenotic (>50%) or occlusive atherosclerotic disease of the infrapopliteal arteries who presented with a reference diameter of between 3.0 and 3.5 mm and a lesion length of <15 mm. The primary safety endpoint was defined as absence of major amputation and/or death within 30 days after index intervention and the primary efficacy endpoint was the 6-month angiographic patency rate as confirmed by core-lab quantitative vessel analysis. The 30-day complication rate was 5.3% (3/57) and 5.0% (3/60) in patients randomized for PTA alone and PTA followed by AMS implantation, respectively. On an intention-to-treat basis, the 6-month angiographic patency rate for lesions treated with AMS (31.8%) was significantly lower (p = 0.013) than the rate for those treated with PTA (58.0%). Although the present study indicates that the AMS technology can be safely applied, it did not demonstrate efficacy in long-term patency over standard PTA in the infrapopliteal vessels.
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree true
33 schema:isPartOf N21f87a8fad3549eebc8cf75cb643163f
34 Na10c6f9986124d78ba3b33da138bc804
35 sg:journal.1091062
36 schema:keywords AMS technology
37 PTA
38 PTA group patients
39 Stenotic
40 absence
41 absorbable metal stents
42 advantages
43 amputation
44 analysis
45 angiographic patency
46 angiographic patency rates
47 angioplasty
48 artery
49 artery lesions
50 atherosclerotic disease
51 basis
52 bioabsorbable stents
53 chronic limb ischemia
54 complication rate
55 controversy
56 critical limb ischemia
57 days
58 death
59 development
60 diameter
61 disease
62 efficacy
63 efficacy endpoint
64 endoluminal treatment
65 endpoint
66 enlargement
67 implantation
68 implants
69 index intervention
70 infrapopliteal arteries
71 infrapopliteal artery lesions
72 infrapopliteal vessels
73 intention
74 intervention
75 ischemia
76 length
77 lesion length
78 lesions
79 limb ischemia
80 long-term patency
81 long-term perspective
82 lumen enlargement
83 major amputation
84 matter
85 matter of controversy
86 means
87 mechanical prevention
88 metal stent implantation
89 metal stents
90 metallic implants
91 new lesions
92 occurrence
93 patency
94 patency rates
95 patients
96 percutaneous transluminal angioplasty
97 permanent metallic implants
98 perspective
99 population
100 positive remodeling
101 possibility
102 present study
103 prevention
104 primary efficacy endpoint
105 primary safety endpoint
106 quantitative vessel analysis
107 rate
108 recoil
109 reference diameter
110 remodeling
111 safety
112 safety endpoint
113 standard PTA
114 stent implantation
115 stents
116 study
117 study population
118 technology
119 transluminal angioplasty
120 treat basis
121 treatment
122 vessel analysis
123 vessel recoil
124 vessels
125 schema:name AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis
126 schema:pagination 424-435
127 schema:productId N3ca8097c2b484ad9b9e46cacb75c3a07
128 N88dc4891f6814639b0237bef45957ffd
129 Nb7d04fc64f00460f937357d6364dcf90
130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029013758
131 https://doi.org/10.1007/s00270-008-9472-8
132 schema:sdDatePublished 2022-05-20T07:24
133 schema:sdLicense https://scigraph.springernature.com/explorer/license/
134 schema:sdPublisher N5944e43ddfff4b93a95065be6d2b46f6
135 schema:url https://doi.org/10.1007/s00270-008-9472-8
136 sgo:license sg:explorer/license/
137 sgo:sdDataset articles
138 rdf:type schema:ScholarlyArticle
139 N0121037a92c94785803a67770cd8a70e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Aged
141 rdf:type schema:DefinedTerm
142 N09001539ad224d438cadd2001dcdb51d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Aged, 80 and over
144 rdf:type schema:DefinedTerm
145 N0948feaa1a9240dd928dad22e72e2495 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Prospective Studies
147 rdf:type schema:DefinedTerm
148 N16bc65a5fa62486cab27d0567c00a22c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Middle Aged
150 rdf:type schema:DefinedTerm
151 N212c22cb7c0a432da949f7fc53e09cb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Peripheral Vascular Diseases
153 rdf:type schema:DefinedTerm
154 N21f87a8fad3549eebc8cf75cb643163f schema:volumeNumber 32
155 rdf:type schema:PublicationVolume
156 N2b935f9034be4ea0bf8b18d682a215f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Treatment Outcome
158 rdf:type schema:DefinedTerm
159 N3b31540410444102bf815865e680d17e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Vascular Patency
161 rdf:type schema:DefinedTerm
162 N3ca8097c2b484ad9b9e46cacb75c3a07 schema:name dimensions_id
163 schema:value pub.1029013758
164 rdf:type schema:PropertyValue
165 N4b6652cecf92403ca096db07574e162f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Female
167 rdf:type schema:DefinedTerm
168 N55534280ca6942d0949211db86bcd622 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Angiography
170 rdf:type schema:DefinedTerm
171 N5944e43ddfff4b93a95065be6d2b46f6 schema:name Springer Nature - SN SciGraph project
172 rdf:type schema:Organization
173 N619cb0b27a98419696362bb649e2fd68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Lower Extremity
175 rdf:type schema:DefinedTerm
176 N7118d9a19a6248b48a33b65a8758f2e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Cross-Over Studies
178 rdf:type schema:DefinedTerm
179 N7892ee6a2670489fb75039f569c30668 schema:affiliation grid-institutes:grid.420039.c
180 schema:familyName On Behalf of the AMS INSIGHT Investigators
181 rdf:type schema:Person
182 N83f4e6fc79424d9098c48e4b506bf48d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Male
184 rdf:type schema:DefinedTerm
185 N88dc4891f6814639b0237bef45957ffd schema:name doi
186 schema:value 10.1007/s00270-008-9472-8
187 rdf:type schema:PropertyValue
188 N8b46f606afd4459f9eeaf14b0ae61a1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Metals
190 rdf:type schema:DefinedTerm
191 Na10c6f9986124d78ba3b33da138bc804 schema:issueNumber 3
192 rdf:type schema:PublicationIssue
193 Na699c2f48a8c4fcabcfebc69a0803868 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Ischemia
195 rdf:type schema:DefinedTerm
196 Na95dc6e65b0a4dcbacea79686654889b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Stents
198 rdf:type schema:DefinedTerm
199 Nac3b44e76db14a4989e177c5ae8f1299 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Salvage Therapy
201 rdf:type schema:DefinedTerm
202 Nb2b8ffc2ba11458983981e3db18e23f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Absorbable Implants
204 rdf:type schema:DefinedTerm
205 Nb7d04fc64f00460f937357d6364dcf90 schema:name pubmed_id
206 schema:value 19093148
207 rdf:type schema:PropertyValue
208 Nb94d1a8f50b14dcb9487f893a8097e50 rdf:first N7892ee6a2670489fb75039f569c30668
209 rdf:rest rdf:nil
210 Nc2eb35057e1f41fdb322db8783b54e06 rdf:first sg:person.01226555721.35
211 rdf:rest Nb94d1a8f50b14dcb9487f893a8097e50
212 Ndf4e6d7a3dea4a74b19ffcebf921b45b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Humans
214 rdf:type schema:DefinedTerm
215 Nf6fb31a0f58b4790899f7e42f831d06a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Statistics, Nonparametric
217 rdf:type schema:DefinedTerm
218 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
219 schema:name Medical and Health Sciences
220 rdf:type schema:DefinedTerm
221 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
222 schema:name Clinical Sciences
223 rdf:type schema:DefinedTerm
224 sg:journal.1091062 schema:issn 0174-1551
225 1432-086X
226 schema:name CardioVascular and Interventional Radiology
227 schema:publisher Springer Nature
228 rdf:type schema:Periodical
229 sg:person.01226555721.35 schema:affiliation grid-institutes:grid.420039.c
230 schema:familyName Bosiers
231 schema:givenName Marc
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226555721.35
233 rdf:type schema:Person
234 sg:pub.10.1007/s00270-004-0341-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028836413
235 https://doi.org/10.1007/s00270-004-0341-9
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s00270-005-0276-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044818355
238 https://doi.org/10.1007/s00270-005-0276-9
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/s00270-007-9292-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042339227
241 https://doi.org/10.1007/s00270-007-9292-2
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s00330-006-0526-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023197907
244 https://doi.org/10.1007/s00330-006-0526-5
245 rdf:type schema:CreativeWork
246 grid-institutes:grid.420039.c schema:alternateName Department of Vascular Surgery, AZ St-Blasius, Kroonveldlaan 50, 9200, Dendermonde, Belgium
247 schema:name Department of Vascular Surgery, AZ St-Blasius, Kroonveldlaan 50, 9200, Dendermonde, Belgium
248 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...